Industry reports
Editor highlights

Publication dates

data types

Schizophrenia Market and Forecasts, April 2014

You might be interested in: mental health, mental illness, medicine, more »


 
1-10 of about 200 reports for Schizophrenia

Mental Disorder Sector Trends in The United States

  • Industry report
  • June 2012
  • 29 pages

... Reduced inhibitory activity excessive excitatory pruning raise rehab raise: recovery after initial schizophrenia episode " Individual resilience training " Family psycho- education ...

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 45 pages
  • by Corporation

... Bipolar in q4 16+) Partnered with otsuka aripiprazole depot vortioxetine opc-34712 expected launch 2015-16 Studies in treatment of schizophrenia and as adjunct in mdd Partnered ...

U.S. Pharmaceutical Business

  • Industry report
  • May 2013
  • 27 pages

... With schizophrenia or bipolar disorder who are using antipsychotic medications- hba1c, glucose test Diabetes monitoring for people with diabetes and schizophrenia- hba1c, ldl-c Cardiovascular monitoring ...

The Swiss Pharmaceutical Business

  • Industry report
  • June 2012
  • 46 pages

... Antipsychotics are going off patent now Typical and atypical antipsychotics inhibit dopamine d2 receptor Address positive symptoms Significant unmet medical need in schizophrenia Negative symptoms ...

Pharmaceutical Market in Switzerland

  • Industry report
  • June 2012
  • 46 pages

... Antipsychotics are going off patent now Typical and atypical antipsychotics inhibit dopamine d2 receptor Address positive symptoms Significant unmet medical need in schizophrenia Negative symptoms ...

Mental Health Business

  • Industry report
  • August 2012
  • 13 pages

... Than those in the general population. Causes of these premature deaths are likely to include treatable health conditions such as heart disease and diabetes. People diagnosed with schizophrenia ...

U.S. Pharmaceutical Business

  • Industry report
  • August 2013
  • 39 pages

... Series in lo (outside of janseen agreement 1 lead identified anxious depression bipolar disorders negative symptoms in schizophrenia preclinical poc in anxiety*, schizophrenia* clinical poc in negative ...

Pharmaceutical Market Overview

  • Industry report
  • May 2013
  • 31 pages

... Cooperation with treatment of concurrent medical disorders also contributed to the increased mortality (kraepelin, 1919). Bleuler - calculated that schizophrenia was associated with an excess mortality ...

Pharmaceutical Sector Overview

  • Industry report
  • June 2012
  • 45 pages

... Right typical and atypical antipsychotics inhibit dopamine d2 receptor Address positive symptoms head2right significant unmet medical need in schizophrenia Negative symptoms like depression ...

Mental Health Market in Canada

  • Industry report
  • October 2012
  • 24 pages

... Although there is some disagreement over which mental disorders qualify as severe and persistent, schizophrenia, bipolar disorder and major depressive disorder are generally categorized as such (bachrach ...

» Purchase Premium Reports (From $ 100 - $ 11 400)

About 4 300 reports for Schizophrenia

» Read our Company Profiles

1 Companies for Schizophrenia

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.